Search Results - "Tripoli, Vincenzo"
-
1
Hematologic toxicity of radium-223 in elderly patients with metastatic Castration Resistant Prostate Cancer: a real-life experience
Published in Prostate international (01-03-2019)“…Treatment with radium-223 has been shown to increase survival and to delay skeletal events related to bone metastases of patients with metastatic Castration…”
Get full text
Journal Article -
2
The Clinical Efficacy of Radium-223 for Bone Metastasis in Patients with Castration-Resistant Prostate Cancer: An Italian Clinical Experience
Published in Oncology (01-01-2018)“…Prostate cancer frequently causes bone metastases and skeletal events that impair quality of life (QoL) and survival. The alpha emitter radium-223 is a new…”
Get more information
Journal Article -
3
Cause of radium 223 treatment discontinuation in elderly mCRPC patients
Published in Journal of clinical oncology (20-02-2018)“…Abstract only 376 Background: Prostate cancer is the most common cancer among adult men. Bones are the main metastatic site of prostate cancer. Radium-223 is…”
Get full text
Journal Article -
4
DOES THE PRESENCE OF THE PRIMARY TUMOR MODIFY THE CLINICAL OUTCOME IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS SUBMITTED TO RADIUM-223 THERAPY?
Published in Anticancer research (01-04-2018)“…Background/Aim: Radium-223 (223Ra) improves survival in patients with metastatic castration-resistant prostate cancer (mCRPC). Although anti-androgen hormonal…”
Get full text
Journal Article -
5
Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated?
Published in Urologic oncology (01-12-2019)“…•The untreated primary prostate cancer could worsen mCRPC outcome during 223Ra.•mCRPC patients with untreated prostate suffer complications due local…”
Get full text
Journal Article -
6
Prognostic Value of the BIO-Ra Score in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223 after the European Medicines Agency Restricted Use: Secondary Investigations of the Multicentric BIO-Ra Study
Published in Cancers (29-03-2022)“…The multicentric retrospective BIO-Ra study combined inflammatory indices from peripheral blood and clinical factors in a composite prognostic score for…”
Get full text
Journal Article -
7
Radium-223 in mCPRC patients: a large real-life Italian multicenter study
Published in Minerva urology and nephrology (01-02-2022)“…Radium-223 is a targeted alpha-particles therapy approved for the treatment of mCRPC patients with symptomatic bone metastases. To our knowledge we account for…”
Get more information
Journal Article -
8
Can radium 223 be a conservative non-surgical management of medication-related osteonecrosis of the jaw?
Published in World journal of nuclear medicine (01-07-2019)“…Osteonecrosis of the jaw (ONJ) is a rare and severe necrotic bone disease reflecting a compromise in the body's osseous healing mechanisms and unique to the…”
Get full text
Journal Article -
9
Ra223 in bone metastases with osteolytic activity
Published in World journal of nuclear medicine (01-04-2018)“…Radium 223 dichloride (Ra223) is the only targeted alpha therapy able to extend survival in patients with bone metastases from prostate cancer. Mechanism of…”
Get full text
Journal Article -
10
-
11
Ra223 in Bone Metastases with Osteolytic Activity
Published in World journal of nuclear medicine (01-04-2018)Get full text
Report